MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-20-2026
Abbott Laboratories Total Non Current Liabilities 2011-2026 | ABT
Annual Total Non Current Liabilities Abbott Laboratories
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 25.7 B | 27.4 B | 36.2 B | 25.3 B | 10.7 B | 9.1 B | 8.18 B | 27.1 B | 20.3 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 36.2 B | 8.18 B | 21.1 B |
Total Non Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
103 K | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
85.2 M | - | - | $ 1.77 B | USA |
 |
Insulet Corporation
PODD
|
1.06 B | $ 216.0 | -4.21 % | $ 15.2 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
24.8 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
35.2 M | - | 1.37 % | $ 20.5 M | USA |
 |
Profound Medical Corp.
PROF
|
2.44 M | $ 5.82 | 13.01 % | $ 180 M |  Canada |
 |
Acutus Medical
AFIB
|
44 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
115 K | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
906 K | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
2.36 M | - | -0.97 % | $ 54.4 M | USA |
 |
Quanterix Corporation
QTRX
|
21.5 M | $ 3.96 | 3.66 % | $ 169 M | USA |
 |
AVITA Medical
RCEL
|
2.35 M | $ 3.99 | 3.91 % | $ 111 M |  Australia |
 |
Conformis
CFMS
|
29.2 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
28.3 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
2.33 M | $ 1.33 | -1.85 % | $ 21.5 M | USA |
 |
Apollo Endosurgery
APEN
|
59 M | - | - | $ 475 M | USA |
 |
IRadimed Corporation
IRMD
|
4.76 M | $ 101.78 | 0.8 % | $ 1.29 B | USA |
 |
Avinger
AVGR
|
12.7 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
400 M | - | -4.14 % | $ 702 M | USA |
 |
Sintx Technologies
SINT
|
1.76 M | $ 2.56 | -0.39 % | $ 7.1 M | USA |
 |
CONMED Corporation
CNMD
|
877 M | $ 37.08 | 1.42 % | $ 1.15 B | USA |
 |
Smith & Nephew plc
SNN
|
4.04 B | - | - | $ 23.8 B |  Britain |
 |
Soliton, Inc.
SOLY
|
4.28 K | - | -1.42 % | $ 435 M | USA |
 |
Sensus Healthcare
SRTS
|
1.66 M | $ 4.22 | 6.57 % | $ 68.9 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
568 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
3.08 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
18 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
8.87 K | $ 24.66 | -0.16 % | $ 208 M | USA |
 |
Misonix, Inc.
MSON
|
39.9 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
8.24 M | - | - | $ 111 M | Canada |
 |
Tactile Systems Technology
TCMD
|
14.1 M | $ 26.96 | 0.37 % | $ 617 M | USA |
 |
TELA Bio
TELA
|
30.2 M | $ 0.69 | -9.35 % | $ 15.8 M | USA |
 |
Intersect ENT, Inc.
XENT
|
116 M | - | - | $ 955 M | USA |
 |
Tandem Diabetes Care
TNDM
|
31.7 M | $ 24.26 | -1.02 % | $ 1.65 B | USA |
 |
Cytosorbents Corporation
CTSO
|
14 M | $ 0.67 | -3.52 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
42.5 K | $ 2.32 | 7.41 % | $ 3.62 M | USA |
 |
BIOLASE
BIOL
|
5.69 M | - | -13.19 % | $ 166 K | USA |
 |
InspireMD
NSPR
|
3.49 M | $ 1.77 | -1.12 % | $ 114 M | Israel |
 |
AdaptHealth Corp.
AHCO
|
424 M | $ 11.39 | -0.78 % | $ 1.54 B | USA |
 |
Penumbra
PEN
|
89.2 M | $ 336.27 | 0.63 % | $ 13.1 B | USA |
 |
Myomo
MYO
|
275 K | $ 0.7 | -0.1 % | $ 29.3 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
6.91 M | $ 2.29 | -4.58 % | $ 134 M | Israel |
 |
Invacare Corporation
IVC
|
325 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
7.44 M | $ 3.71 | -5.12 % | $ 138 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
116 M | $ 16.23 | 2.01 % | $ 381 M | USA |
 |
Outset Medical
OM
|
436 M | $ 3.53 | - | $ 53.7 K | USA |
 |
Inspire Medical Systems
INSP
|
24.6 M | $ 51.41 | -1.27 % | $ 1.51 B | USA |
 |
Varex Imaging Corporation
VREX
|
419 M | $ 10.69 | 0.66 % | $ 443 M | USA |